
Academic Journal
Q1npj Digital Medicine
About npj Digital Medicine
npj Digital Medicine is a scholarly journal published by Nature Publishing Group. SCImago 2025 places it in Q1 with an SJR of 4.215 and an H-index of 130.
Its listed coverage is 2018-2026 and its research categories include Computer Science Applications (Q1); Health Informatics (Q1); Health Information Management (Q1); Medicine (miscellaneous) (Q1). The 2025 dataset reports 788 documents and 14522 citations across the latest three-year reporting window.
Exploring npj Digital Medicine: A Leading Journal in Digital Health Innovation
npj Digital Medicine is a high-impact, peer-reviewed, open-access journal published by Nature Research in partnership with the Scripps Research Translational Institute. As the field of digital medicine continues to revolutionize healthcare, npj Digital Medicine stands at the forefront, providing a trusted platform for cutting-edge research, clinical insights, and technological innovations that are transforming patient care.
What is npj Digital Medicine?
Launched in 2018, npj Digital Medicine is part of the Nature Partner Journals (NPJ) series. It focuses on the intersection of healthcare and digital technologies, covering a wide range of topics such as mobile health (mHealth), telemedicine, artificial intelligence (AI), wearable technology, remote monitoring, big data analytics, and electronic health records (EHR). The journal’s mission is to advance knowledge and implementation of digital tools that can improve health outcomes, enhance healthcare delivery, and empower patients.
Key Areas of Research
The journal welcomes original research, reviews, perspectives, and commentary on all aspects of digital health, including but not limited to:
-
Artificial Intelligence in Medicine: AI algorithms for diagnostics, clinical decision support, and predictive analytics.
-
Mobile Health and Wearables: Devices and applications that track health metrics in real time.
-
Telehealth and Remote Patient Monitoring: Innovations enabling virtual care and chronic disease management from a distance.
-
Digital Therapeutics: Software-driven interventions for prevention, management, or treatment of medical conditions.
-
Health Informatics: Integration and analysis of health data from diverse sources for better patient insights.
Why npj Digital Medicine Matters
In an era where healthcare systems are under pressure to become more efficient and patient-centered, digital medicine offers scalable and sustainable solutions. npj Digital Medicine plays a crucial role in validating these technologies through rigorous scientific evaluation. By bridging the gap between research and real-world clinical application, the journal helps stakeholders—including clinicians, researchers, technologists, and policymakers—understand and adopt digital tools effectively.
High-Impact and Open Access
One of the standout features of npj Digital Medicine is its open-access model, ensuring that all published articles are freely available to the global scientific and medical communities. This democratization of information fosters wider dissemination of knowledge, enhances collaboration, and accelerates innovation in the digital health ecosystem.
Moreover, with a rising impact factor and contributions from renowned experts worldwide, the journal has quickly established itself as a leading voice in the field. Its association with Nature ensures high editorial standards, robust peer review, and global visibility.
Who Should Read npj Digital Medicine?
-
Healthcare Professionals seeking evidence-based digital solutions.
-
Researchers focused on AI, data science, and health informatics.
-
Technology Developers innovating in digital health tools.
-
Policy Makers and Health Administrators interested in digital transformation in healthcare.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Exploring the Scope of npj Digital Medicine: Advancing the Future of Healthcare
npj Digital Medicine is a leading peer-reviewed, open-access journal published by Nature Portfolio in partnership with the Scripps Research Translational Institute. As digital technologies continue to reshape the landscape of modern healthcare, npj Digital Medicine stands at the forefront, offering a dedicated platform for high-quality research that bridges the gap between technological innovation and clinical application.
What is the Scope of npj Digital Medicine?
The journal covers a broad spectrum of topics that intersect healthcare and digital innovation. Its scope is designed to foster interdisciplinary research and accelerate the translation of digital tools into clinical practice. Key areas of focus include:
-
Artificial Intelligence (AI) in Healthcare: The journal publishes studies leveraging machine learning and AI to enhance diagnostics, predictive modeling, and personalized medicine.
-
Mobile and Wearable Health Technologies: Research on mobile health apps, wearable sensors, and remote monitoring tools that empower patients and clinicians alike.
-
Telemedicine and Virtual Care: Innovations in telehealth, virtual consultations, and digital platforms that improve access to care, particularly in underserved regions.
-
Health Data Science and Big Data Analytics: Articles focusing on the integration and analysis of large-scale health datasets to derive actionable insights and optimize care delivery.
-
Digital Therapeutics and Behavioral Interventions: Evidence-based digital interventions targeting chronic disease management, mental health, and behavioral change.
-
Cybersecurity and Data Privacy in Digital Health: Discussions around securing health information systems and maintaining patient confidentiality in an increasingly connected world.
A Platform for Global Collaboration
npj Digital Medicine invites contributions from researchers, clinicians, data scientists, policy makers, and technologists across the globe. The journal emphasizes multidisciplinary collaboration, encouraging submissions that incorporate insights from medicine, computer science, engineering, and the social sciences.
With its open-access model, the journal ensures that groundbreaking research is freely available to clinicians, health system leaders, and patients worldwide. This approach supports rapid dissemination of knowledge and fosters real-world implementation of digital solutions.
Commitment to Scientific Rigor and Innovation
All submissions to npj Digital Medicine undergo a rigorous peer-review process, ensuring that published studies meet the highest scientific standards. The journal also highlights translational impact—emphasizing practical applicability, scalability, and outcomes that drive improvement in patient care.
Why It Matters
As digital health becomes an essential pillar of 21st-century medicine, the need for robust evidence and thoughtful integration is more important than ever. npj Digital Medicine serves as a trusted resource for those shaping the digital health revolution—offering insights, analysis, and evidence to guide innovation with integrity.
Whether you're a healthcare professional exploring new technologies, a developer working on the next breakthrough app, or a policymaker crafting future-ready regulations, npj Digital Medicine offers the content and community to inform and inspire.
Recent Research Articles
Latest publications matched automatically by ISSN.
A global framework for artificial intelligence education in medicine: international working group recommendations
Laura C. Rosella, Yindalon Aphinyanaphongs, James Barry, Orest Boyko et al.
2026-09-09 · DOI: 10.1038/s41746-026-03197-xPREDICT-GBM: A multicenter platform advancing personalized glioblastoma radiotherapy planning
Lucas Zimmer, Jonas Weidner, Michal Balcerak, Florian Kofler et al.
2026-09-09 · DOI: 10.1038/s41746-026-03194-0A domain-specific large language model for evidence-based nursing: development and multi-method evaluation of EviNurse
Junyi Ruan, Shangzhe Dai, Zhijie Bao, Zhongyu Wei et al.
2026-09-09 · DOI: 10.1038/s41746-026-03229-6Impact of LLM assistance on physician decision-making: a multi-country randomized controlled trial
Nicholas Rounding, Luthfi Saiful Arif, Janine Berg, Jochen Cals et al.
2026-09-09 · DOI: 10.1038/s41746-026-03111-5DystoniaDBSNet as a novel deep learning biomarker of predictive deep brain stimulation outcome in dystonia
Dongren Yao, Giovanni Battistella, Nutan Sharma, Emad Eskandar et al.
2026-09-09 · DOI: 10.1038/s41746-026-03235-8AI-derived carotid plaque vulnerability from B-mode ultrasound for cerebrovascular risk stratification: a multicenter cohort study
Qi Xu, Huanhuan Ding, Lin Zhou, Xiaoli Ji et al.
2026-09-08 · DOI: 10.1038/s41746-026-03201-4Intervention fidelity and competency translation of serious games in pharmacy education: a scoping umbrella review
Yilin Yu, Minkai Wang, Yulin Gong, Di Zhang et al.
2026-09-08 · DOI: 10.1038/s41746-026-03182-4Identifying potential nonpulmonary vein triggers in persistent atrial fibrillation using digital twins and deep learning
Kensuke Sakata, Ishan Vatsaraj, Adityo Prakosa, Carolyna A. P. Yamamoto et al.
2026-09-08 · DOI: 10.1038/s41746-026-03223-yAn explainable detection framework for health insurance fraud via temporal capture and confidence assurance
Ben Niu, Ning Liu, Qingli Zhang, Gustave Florentin Nkoulou Mvondo et al.
2026-09-08 · DOI: 10.1038/s41746-026-03200-5Multimodal artificial intelligence integrating peritumoral MRI and clinical data stratifies meningioma recurrence risk after radiotherapy
Leihao Ren, Jiaojiao Deng, Tianqi Wu, Renhua Huang et al.
2026-09-07 · DOI: 10.1038/s41746-026-03202-3Senescence-aware filtering facilitates robust prediction of cancer immunotherapy outcomes
Minsoo Kim, Woomin Song, Hyunsoo Ahn, Giljae Chung et al.
2026-09-05 · DOI: 10.1038/s41746-026-03131-1From feasibility to neuroanatomic validity of remote cognitive smartphone assessments in early Alzheimer’s disease
Kirsten I. Taylor, Arnaud M. Wolfer, Irma T. Kurniawan, Miguel Veloso et al.
2026-09-05 · DOI: 10.1038/s41746-026-03108-0Unsupervised machine learning for placental disease using cell spatial organization
Mangalam Sahai, Liron Pantanowitz, Philip LeDuc, Jonathan Cagan et al.
2026-09-05 · DOI: 10.1038/s41746-026-03177-1Exploring generalizability and explainability of LLMs in classifying clinically rated suicidal ideation using heterogeneous data
Rong Huang, Longdi Xian, Christopher Chi Wai Cheng, Jie Chen et al.
2026-09-05 · DOI: 10.1038/s41746-026-03198-wA voice-biomarker foundation model for ALS monitoring and Parkinson’s screening
Arturo Loaiza-Bonilla, Pranav Arora, Nathan Hayman, Andres Deik et al.
2026-09-04 · DOI: 10.1038/s41746-026-03206-zPlatforms for artificial intelligence-enabled infectious disease surveillance
Marya Getchell, Michael Barber, Thomas Carpino, Carl J. E. Suster et al.
2026-09-04 · DOI: 10.1038/s41746-026-03189-xThe illusion of clinical reasoning: a benchmark reveals the pervasive gap in vision-language models for clinical competency
Dingyu Wang, Zimu Yuan, Jiajun Liu, Shanggui Liu et al.
2026-09-03 · DOI: 10.1038/s41746-026-03191-3A five-phase evaluation framework for diagnostic and predictive medical artificial intelligence
Zichen Ye, Yue Chen, Xuefeng Huang, Manman Chen et al.
2026-09-03 · DOI: 10.1038/s41746-026-03155-7Explicit chain of diagnosis for CMR semantic interpretation via large reasoning model
YanSong Li, JinYu Zheng, Yun Tian, ShiFeng Zhao et al.
2026-09-03 · DOI: 10.1038/s41746-026-03175-3Differences in tone of AI and care team responses to patient messages by patient demographics
Angela Mastrianni, William R. Small, Yuhan Betty Cui, Amelia Shunk et al.
2026-09-03 · DOI: 10.1038/s41746-026-03185-1Reviews
Community Reviews
Version History
April 23, 2025 at 11:49 am
April 23, 2025